StockpollyBeta
Get App
Popularity #2,476
RXST · NASDAQ · Medical - Devices

RxSight (RXST)

Sells adjustable cataract lenses, light-delivery devices, and related service for ophthalmology practices.

$4.93
After hours0.00 (0.00%)
At close$4.93(−4.09%)

In millions of USD, except per-share figures

In millionsQ3 FY23Sep 2023Q4 FY23Dec 2023Q1 FY24Mar 2024Q2 FY24Jun 2024Q3 FY24Sep 2024Q4 FY24Dec 2024Q1 FY25Mar 2025Q2 FY25Jun 2025Q3 FY25Sep 2025Q4 FY25Dec 2025Q1 FY26Mar 2026Q2 FY26Jun 2026
Revenue312930354540383430333134
Cost of revenue171191120111086778
Gross profit141821242529282524252326
262931333437393936374140
Research & development77889910109999
Selling, general & administrative192123242628292927283230
Operating income−13−11−11−8−9−9−11−14−12−11−18−14
022233322222
Interest income222233322222
Interest expense000000000000
Other non-operating income0−2−2−2−3−3−3−2−2−2−2−2
Income before tax−12−9−9−6−6−6−8−12−10−9−16−12
Income tax expense000000000000
Net income from continuing operations−12−9−9−6−6−6−8−12−10−9−16−12
Net income−12−9−9−6−6−6−8−12−10−9−16−12
EPS, basic−$0.35−$0.26−$0.25−$0.16−$0.16−$0.15−$0.20−$0.29−$0.24−$0.22−$0.38−$0.29
EPS, diluted−$0.35−$0.26−$0.25−$0.16−$0.16−$0.15−$0.20−$0.29−$0.24−$0.22−$0.38−$0.29
Weighted average shares, basic363637384040414141414141
Weighted average shares, diluted363637384040414141414141
EBITDA−11−8−8−5−5−5−7−11−9−8−15−11
Depreciation & amortization111111111111
EBIT−12−9−9−6−6−6−8−12−10−9−16−12